MoneyWorks4Me

Hexagon Nutrition - Quaterly Results

01 Jul 2026 Evaluate
A fair growth of 18.00% in the revenue at Rs. 984.71 millions was reported in the March 2026 quarter as compared to Rs. 834.53 millions during year-ago period.The Net Profit of the company reported a remarkable increase of 105.29% to Rs. 136.33  millions  from Rs. 66.41 millions in previous same quarter.Operating profit for the quarter ended March 2026 rose to 201.48 millions as compared to 108.02 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 984.71 834.53 18.00 3191.20 2674.47 19.32 3191.20 2674.47 19.32
Other Income 61.50 22.21 176.90 152.14 100.82 50.90 152.14 100.82 50.90
PBIDT 201.48 108.02 86.52 585.13 438.24 33.52 585.13 438.24 33.52
Interest 6.24 5.18 20.46 18.82 21.03 -10.51 18.82 21.03 -10.51
PBDT 198.44 102.66 93.30 569.87 414.60 37.45 569.87 414.60 37.45
Depreciation 16.46 13.49 22.02 57.44 49.88 15.16 57.44 49.88 15.16
PBT 181.98 89.17 104.08 512.43 364.72 40.50 512.43 364.72 40.50
TAX 45.65 22.76 100.57 130.95 95.03 37.80 130.95 95.03 37.80
Deferred Tax 0.14 -1.39 -110.07 -2.08 -1.72 20.93 -2.08 -1.72 20.93
PAT 136.33 66.41 105.29 381.48 269.69 41.45 381.48 269.69 41.45
Equity 110.63 110.63 0.00 110.63 110.63 0.00 110.63 110.63 0.00
PBIDTM(%) 20.46 12.94 58.07 18.34 16.39 11.90 18.34 16.39 11.90
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..